We can use these cytokines to test whether they are able to redirect the differentiation of mouse LSCs in B-lymphocyte and T-lymphocyte leukaemias, and whether Epo can divert LSCs in myeloid leukaemia towards erythropoiesis. Here, EPO is linked to myeloid leukemia.